Promoter methylation of MLH1, PMS2, MSH2 and p16 was analysed by MSP in tumour and non-tumour adjacent tissue of 61 patients with HCC of which 34 were associated with HCV, 10 with HBV and 17 with alcoholic liver disease (Table 1). This evidence concerns the gene CDKN2A and alcoholic liver diseases.